NCT00903331 Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study Status COMPLETED Phase PHASE2
NCT00879229 ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis Status TERMINATED Phase PHASE3
NCT00768300 (ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF Status TERMINATED Phase PHASE3
NCT00705133 Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE2
NCT00703339 Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis Status TERMINATED Phase PHASE2
NCT00662038 Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE3
NCT00637065 Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study Status UNKNOWN Phase PHASE4
NCT00631475 Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443 Status COMPLETED Phase PHASE3
NCT00625469 Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan Status WITHDRAWN Phase PHASE4
NCT00625079 Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil Status WITHDRAWN Phase PHASE4
NCT00600028 Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide Status COMPLETED Phase PHASE3
NCT00518310 Azathioprine and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis Status UNKNOWN Phase NA
NCT00512967 The Occurence of Inflammation and Oxidative Stress in Lung Diseases Status COMPLETED Phase N/A
NCT00470327 A Study of the Natural Progression of Interstitial Lung Disease (ILD) Status RECRUITING Phase N/A
NCT00463983 Treatment of Idiopathic Pulmonary Fibrosis with Long Acting Octreotide Status COMPLETED Phase PHASE1/PHASE2